MT Newswires07-22
Lonza's (SGX:O6Z) attributable profit to equity holders during the first half of the year rose to 591 million Swiss francs from 426 million francs a year earlier, according to a Wednesday filing with the Singapore Exchange.
Earnings per share rose to 8.16 francs compared with 5.67 francs in the year-ago period.
The Swiss pharmaceutical company's sales rose 11% year over year to 3.37 billion francs from 3.03 billion francs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
